BioAge Labs, Inc (BIOA) — Financial Flexibility Index
BioAge Labs, Inc (BIOA) has a Financial Flexibility Index of -0.58x as of September 2025. Free cash flow of $-16.02 Million (operating CF $-16.04 Million minus capex $22.00K) represents -1% of total liabilities ($27.63 Million). Check BIOA capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioAge Labs, Inc Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for BioAge Labs, Inc across 8 annual periods. See BioAge Labs, Inc (BIOA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BioAge Labs, Inc (2013–2024)
Year-by-year free cash flow to debt coverage for BioAge Labs, Inc. For the full company profile including market capitalisation, see BioAge Labs, Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.46x | $-51.16 Million | $-51.52 Million | $35.11 Million | ▼ -680.8% |
| 2023 | -0.19x | $-37.20 Million | $-37.36 Million | $199.32 Million | ▲ +27.1% |
| 2022 | -0.26x | $-36.08 Million | $-36.18 Million | $140.99 Million | ▲ +59.1% |
| 2017 | -0.63x | $-29.79 Million | $-29.79 Million | $47.66 Million | ▼ -87.5% |
| 2016 | -0.33x | $-37.62 Million | $-37.62 Million | $112.84 Million | ▼ -0.1% |
| 2015 | -0.33x | $-32.20 Million | $-32.20 Million | $96.73 Million | ▼ -40.7% |
| 2014 | -0.24x | $-22.45 Million | $-22.45 Million | $94.91 Million | ▲ +21.2% |
| 2013 | -0.30x | $-14.74 Million | $-27.52 Million | $49.07 Million | — |